MENU
PBE
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS
Invesco Biotechnology & Genome ETF (PBE) Ownership - Who owns Invesco Biotechnology & Genome ETF?
Category: @Health
Profile
Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com
Details
Group
Domestic Stock Funds
Category
Health
Net Assets
255447220.00
Fund Existence
over 19 years
Turnover
71.00
Capitalization
N/A
Yield
0.06
Total Expense Ratio
N/A
Investment Style
N/A
Risk (Beta)
N/A
Fundamentals
PBE
Net Assets
255M
Yield
0.06
Fund Existence
over 19 years
Total Expense Ratio
N/A
Turnover
71.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
N/A
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
N/A
Assets in Top Ten Holdings
110M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
255M
Fund Type
ETF
Index Fund
No
Management Fee
N/A
Modified Duration
N/A
No Load Fund
No
Number of Long Holdings
32.00
Number of Net Holdings
N/A
Number of Short Holdings
1.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
N/A
Gain YTD
4.548
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com